Removal of Alpha-Amanitin from Blood by Hemoperfusion over Uncoated Charcoal Experimental Results1

E. Masini,P. Blandina,P. F. Mannaioni
DOI: https://doi.org/10.1159/000406179
2024-05-18
Contributions to Nephrology
Abstract:The sorbent capacity of uncoated charcoal column (Detoxyl 2, Sorin Biomedica) on alpha-amanitin was studied by adding known amounts of alpha-amanitin to fresh human blood, which was recirculated through a clinical hemoperfusion circuit over a period of 30 min. The column was washed with saline to remove loosely bound alpha-amanitin, and eluted with 0.1 N HCl to detach absorbed alpha-amanitin. Alpha-amanitin concentration was measured in the saline washings and in the acid eluates by means of a radioimmunoassay. Only negligible amounts of amanitin were recovered in the saline washings. Suitable amounts of alpha-amanitin were present in the acid eluates, showing an adsorption optimum for blood concentrations ranging from 50 to 200 ng . ml-1. The results were discussed as predictable of the clinical usefulness of charcoal hemoperfusion in A. phalloides poisoning.
urology & nephrology
What problem does this paper attempt to address?
The paper primarily investigates the effectiveness of hemoperfusion using uncoated activated carbon to remove α-amanitin. Specifically, the paper attempts to address the following issues: 1. **Verify the adsorption capacity of uncoated activated carbon for α-amanitin**: Researchers conducted experiments to verify whether uncoated activated carbon can effectively adsorb α-amanitin in the blood. 2. **Evaluate the adsorption effect at different concentrations**: The study explored the adsorption effect of uncoated activated carbon on α-amanitin at different initial concentrations (ranging from 50 to 1000 ng/ml). 3. **Explore the possibility of clinical application**: Although experimental results indicate that uncoated activated carbon has good adsorption capacity, the paper also discusses the limitations and potential risks of this technique in clinical applications. Overall, this paper aims to demonstrate the effectiveness and feasibility of hemoperfusion with uncoated activated carbon for the treatment of acute α-amanitin poisoning through experimental data, providing a theoretical basis for further clinical applications.